BioCentury | Dec 9, 2013
Company News

AdAlta, Crossbeta Biosciences deal

...to disclose details, and Crossbeta could not be reached. AdAlta Pty. Ltd. , Bundoora, Australia Crossbeta Biosciences B.V....
BioCentury | Mar 11, 2013
Financial News

Crossbeta Biosciences completes venture financing

Crossbeta Biosciences B.V. , Utrecht, the Netherlands Business: Neurology Date completed: 3/3/13 Type: Venture financing Raised: Not disclosed Investors: New investors; existing investors WIR Staff Neurology...
BioCentury | Oct 3, 2011
Company News

ArenaVax AG, Crossbeta Biosciences, deCode genetics, Intercell, Okairos, Pevion Biotech, Sigmoid Pharma, Vaccibody, Xbrane Bioscience AB, Novartis infectious ne

...the effects of gender, chronic diseases and genetic variation on vaccination. ArenaVax AG , Switzerland Crossbeta Biosciences B.V....
BioCentury | Sep 30, 2011
Company News

EC provides EUR 30M to international vaccine program

...chronic diseases and genetic variation on vaccination. Companies participating in ADITEC include: ArenaVax AG (Switzerland); Crossbeta Biosciences B.V....
BioCentury | Sep 25, 2008
Targets & Mechanisms

New Roles for Old Factor

...Researchers at the University Medical Center Utrecht and Crossbeta Biosciences B.V. have linked high levels of activated Factor...
...as a therapeutic target. Companies and Institutions Mentioned Case Western Reserve University , Cleveland, Ohio Crossbeta Biosciences B.V....
BioCentury | Sep 11, 2008
Distillery Therapeutics

This Week in Therapeutics

...least four other companies have compounds in clinical development to treat amyloidosis. Patented; licensed to Crossbeta Biosciences B.V....
Items per page:
1 - 6 of 6
BioCentury | Dec 9, 2013
Company News

AdAlta, Crossbeta Biosciences deal

...to disclose details, and Crossbeta could not be reached. AdAlta Pty. Ltd. , Bundoora, Australia Crossbeta Biosciences B.V....
BioCentury | Mar 11, 2013
Financial News

Crossbeta Biosciences completes venture financing

Crossbeta Biosciences B.V. , Utrecht, the Netherlands Business: Neurology Date completed: 3/3/13 Type: Venture financing Raised: Not disclosed Investors: New investors; existing investors WIR Staff Neurology...
BioCentury | Oct 3, 2011
Company News

ArenaVax AG, Crossbeta Biosciences, deCode genetics, Intercell, Okairos, Pevion Biotech, Sigmoid Pharma, Vaccibody, Xbrane Bioscience AB, Novartis infectious ne

...the effects of gender, chronic diseases and genetic variation on vaccination. ArenaVax AG , Switzerland Crossbeta Biosciences B.V....
BioCentury | Sep 30, 2011
Company News

EC provides EUR 30M to international vaccine program

...chronic diseases and genetic variation on vaccination. Companies participating in ADITEC include: ArenaVax AG (Switzerland); Crossbeta Biosciences B.V....
BioCentury | Sep 25, 2008
Targets & Mechanisms

New Roles for Old Factor

...Researchers at the University Medical Center Utrecht and Crossbeta Biosciences B.V. have linked high levels of activated Factor...
...as a therapeutic target. Companies and Institutions Mentioned Case Western Reserve University , Cleveland, Ohio Crossbeta Biosciences B.V....
BioCentury | Sep 11, 2008
Distillery Therapeutics

This Week in Therapeutics

...least four other companies have compounds in clinical development to treat amyloidosis. Patented; licensed to Crossbeta Biosciences B.V....
Items per page:
1 - 6 of 6